A significant decrease in H3K4me3 and H3K27ac at the PHLDA1 locus was also observed in MFE-296 endometrial cancer cells treated for seven days with the FGFR inhibitor PD173074 (Figure S3). The gene discussed is PHLDA1; the disease is endometrial cancer.